These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 25386646)

  • 1. Effect of the CALHM1 G330D and R154H human variants on the control of cytosolic Ca2+ and Aβ levels.
    Vingtdeux V; Tanis JE; Chandakkar P; Zhao H; Dreses-Werringloer U; Campagne F; Foskett JK; Marambaud P
    PLoS One; 2014; 9(11):e112484. PubMed ID: 25386646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rare variants in calcium homeostasis modulator 1 (CALHM1) found in early onset Alzheimer's disease patients alter calcium homeostasis.
    Rubio-Moscardo F; Setó-Salvia N; Pera M; Bosch-Morató M; Plata C; Belbin O; Gené G; Dols-Icardo O; Ingelsson M; Helisalmi S; Soininen H; Hiltunen M; Giedraitis V; Lannfelt L; Frank A; Bullido MJ; Combarros O; Sánchez-Juan P; Boada M; Tárraga L; Pastor P; Pérez-Tur J; Baquero M; Molinuevo JL; Sánchez-Valle R; Fuentes-Prior P; Fortea J; Blesa R; Muñoz FJ; Lleó A; Valverde MA; Clarimón J
    PLoS One; 2013; 8(9):e74203. PubMed ID: 24069280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CALHM1 and its polymorphism P86L differentially control Ca²⁺homeostasis, mitogen-activated protein kinase signaling, and cell vulnerability upon exposure to amyloid β.
    Moreno-Ortega AJ; Buendia I; Mouhid L; Egea J; Lucea S; Ruiz-Nuño A; López MG; Cano-Abad MF
    Aging Cell; 2015 Dec; 14(6):1094-102. PubMed ID: 26416646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CALHM1 P86L polymorphism modulates CSF Aβ levels in cognitively healthy individuals at risk for Alzheimer's disease.
    Koppel J; Campagne F; Vingtdeux V; Dreses-Werringloer U; Ewers M; Rujescu D; Hampel H; Gordon ML; Christen E; Chapuis J; Greenwald BS; Davies P; Marambaud P
    Mol Med; 2011; 17(9-10):974-9. PubMed ID: 21629967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease risk.
    Dreses-Werringloer U; Lambert JC; Vingtdeux V; Zhao H; Vais H; Siebert A; Jain A; Koppel J; Rovelet-Lecrux A; Hannequin D; Pasquier F; Galimberti D; Scarpini E; Mann D; Lendon C; Campion D; Amouyel P; Davies P; Foskett JK; Campagne F; Marambaud P
    Cell; 2008 Jun; 133(7):1149-61. PubMed ID: 18585350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondria sense with different kinetics the calcium entering into HeLa cells through calcium channels CALHM1 and mutated P86L-CALHM1.
    Moreno-Ortega AJ; Ruiz-Nuño A; García AG; Cano-Abad MF
    Biochem Biophys Res Commun; 2010 Jan; 391(1):722-6. PubMed ID: 19944073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CALHM1 ion channel elicits amyloid-β clearance by insulin-degrading enzyme in cell lines and in vivo in the mouse brain.
    Vingtdeux V; Chandakkar P; Zhao H; Blanc L; Ruiz S; Marambaud P
    J Cell Sci; 2015 Jul; 128(13):2330-8. PubMed ID: 25999473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of implication for CALHM1 P86L common variation in Italian patients with early and late onset Alzheimer's disease.
    Nacmias B; Tedde A; Bagnoli S; Lucenteforte E; Cellini E; Piaceri I; Guarnieri BM; Bessi V; Bracco L; Sorbi S
    J Alzheimers Dis; 2010; 20(1):37-41. PubMed ID: 20164602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium homeostasis modulator 1 (CALHM1) is the pore-forming subunit of an ion channel that mediates extracellular Ca2+ regulation of neuronal excitability.
    Ma Z; Siebert AP; Cheung KH; Lee RJ; Johnson B; Cohen AS; Vingtdeux V; Marambaud P; Foskett JK
    Proc Natl Acad Sci U S A; 2012 Jul; 109(28):E1963-71. PubMed ID: 22711817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CLHM-1 is a functionally conserved and conditionally toxic Ca2+-permeable ion channel in Caenorhabditis elegans.
    Tanis JE; Ma Z; Krajacic P; He L; Foskett JK; Lamitina T
    J Neurosci; 2013 Jul; 33(30):12275-86. PubMed ID: 23884934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CALHM1 variant is not associated with Alzheimer's disease among Asians.
    Tan EK; Ho P; Cheng SY; Yih Y; Li HH; Fook-Chong S; Lee WL; Zhao Y
    Neurobiol Aging; 2011 Mar; 32(3):546.e11-2. PubMed ID: 19545933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium homeostasis modulator (CALHM) ion channels.
    Ma Z; Tanis JE; Taruno A; Foskett JK
    Pflugers Arch; 2016 Mar; 468(3):395-403. PubMed ID: 26603282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No association between CALHM1 polymorphism and Alzheimer's disease risk in a Hungarian population.
    Fehér A; Juhász A; Rimanóczy A; Pákáski M; Kálmán J; Janka Z
    Psychiatr Genet; 2011 Oct; 21(5):249-52. PubMed ID: 21378601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CALHM1 polymorphism is not associated with late-onset Alzheimer disease.
    Beecham GW; Schnetz-Boutaud N; Haines JL; Pericak-Vance MA
    Ann Hum Genet; 2009 May; 73(Pt 3):379-81. PubMed ID: 19472444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The P86L common allele of CALHM1 does not influence risk for Alzheimer disease in Japanese cohorts.
    Inoue K; Tanaka N; Yamashita F; Sawano Y; Asada T; Goto YI
    Am J Med Genet B Neuropsychiatr Genet; 2010 Mar; 153B(2):532-535. PubMed ID: 19655363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CALHM1 controls the Ca²⁺-dependent MEK, ERK, RSK and MSK signaling cascade in neurons.
    Dreses-Werringloer U; Vingtdeux V; Zhao H; Chandakkar P; Davies P; Marambaud P
    J Cell Sci; 2013 Mar; 126(Pt 5):1199-206. PubMed ID: 23345406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No association between CALHM1 and risk for Alzheimer dementia in a Belgian population.
    Sleegers K; Brouwers N; Bettens K; Engelborghs S; van Miegroet H; De Deyn PP; Van Broeckhoven C
    Hum Mutat; 2009 Apr; 30(4):E570-4. PubMed ID: 19191332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic association between CALHM1, 2, and 3 polymorphisms and Alzheimer's disease in a Japanese population.
    Shibata N; Kuerban B; Komatsu M; Ohnuma T; Baba H; Arai H
    J Alzheimers Dis; 2010; 20(2):417-21. PubMed ID: 20164573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linking calcium to Abeta and Alzheimer's disease.
    Green KN; LaFerla FM
    Neuron; 2008 Jul; 59(2):190-4. PubMed ID: 18667147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A polymorphism in CALHM1 is associated with temporal lobe epilepsy.
    Lv RJ; He JS; Fu YH; Shao XQ; Wu LW; Lu Q; Jin LR; Liu H
    Epilepsy Behav; 2011 Apr; 20(4):681-5. PubMed ID: 21439911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.